The Cannabist Bankruptcy: How a Top MSO Lost Everything

In late March 2026, a major American multistate cannabis operator did something that the industry had been quietly bracing for and loudly denying might happen. The Cannabist Co. — formerly known as Columbia Care, one of the largest licensed cannabis operators in the country — filed for bankruptcy protection in U.S. Bankruptcy Court in Delaware, immediately after filing parallel proceedings in Canada, where the company is incorporated.

The headline number is $270 million. That's how much The Cannabist owes its lenders and the IRS combined, even after pre-bankruptcy asset sales that generated tens of millions in cash. It is the first formal bankruptcy by a top-five U.S. cannabis MSO. It will not be the last.

This is the story of how a company that once carried multi-billion-dollar valuations and operated in more than a dozen states became a Chapter 11 cautionary tale.

What The Cannabist Was

The Cannabist Co. did not start as The Cannabist. The company began as Columbia Care, founded in 2012 in New York as a medical cannabis pioneer. By the late 2010s, Columbia Care had built one of the largest national footprints in regulated cannabis — operations or licenses in roughly 18 states, vertically integrated cultivation and retail, partnerships with major retail brands, and a public listing on the Canadian exchanges where U.S. cannabis companies typically trade.

The company rebranded as The Cannabist in 2024 as part of a strategic refocusing on consumer brand identity. By that point, the headwinds were already visible: declining wholesale prices, mounting debt service costs, the inescapable burden of Section 280E federal taxation, and the chronic capital shortage that hits federally illegal businesses regardless of revenue.

The rebrand did not save the company. It became a more brand-focused version of the same operating company, with the same financial structure, facing the same maturity calendar.

What Triggered the Filing

The proximate cause of the March 2026 bankruptcy was a major loan default earlier in the year. The company had been negotiating refinancing terms with its lenders since 2025, with progressively narrower options as maturity dates approached and the lenders' patience evaporated.

When the loan default hit, The Cannabist began an emergency disposal of assets. Cannabis licenses in Virginia, Ohio, and Delaware were sold off in a combination of cash and promissory notes, generating approximately $63.5 million plus future obligations. The company surrendered its medical cannabis permit in New York. It announced it was winding down operations in Pennsylvania.

Even with those sales, the lender debt and IRS obligations vastly exceeded available cash. The choice was between a chaotic forced liquidation or a controlled Chapter 11 process. Management chose the controlled process, filed in Canada first to take advantage of cross-border restructuring tools, then filed in U.S. Bankruptcy Court in Delaware to formalize the U.S. proceedings.

The Cannabist is now in the process of selling licenses in six additional states to satisfy creditors. The remaining business will be a fraction of what existed eighteen months earlier.

The IRS Is at the Front of the Line

One of the most consequential details in the Cannabist filings is the listing of the Internal Revenue Service as a major creditor. The unpaid federal tax balance that The Cannabist had been carrying — part of the broader MSO strategy of withholding 280E tax payments pending litigation outcomes — became, at the moment of bankruptcy filing, a senior priority claim against the company's remaining assets.

Tax claims in U.S. bankruptcy proceedings have specific priority treatment. Recent unpaid federal taxes are typically classified as administrative or priority unsecured claims, depending on the timing and nature of the obligations. They generally must be paid in full before general unsecured creditors receive anything, and in some cases ahead of secured creditors as well.

For The Cannabist's lenders, the IRS presence at the front of the priority line means recoveries will be lower than anticipated. For other MSOs running the same withhold-and-litigate strategy, The Cannabist filing is a stark preview of how that strategy looks when it ends in bankruptcy. The accumulated tax debt becomes a senior claim that cannot be negotiated away.

The Department of Justice and the IRS have legal tools to collect against cannabis operators in bankruptcy that are different from the tools they have outside bankruptcy. Asset disposition supervised by a bankruptcy court can produce more reliable tax recoveries than years of administrative collection efforts against an operating business.

What the Asset Sales Tell Us

The license sales The Cannabist has executed in Virginia, Ohio, and Delaware reveal something important about the underlying value of cannabis assets in distressed sales.

The Virginia sale — to an affiliate of a Boston-based hedge fund — disposed of a vertically integrated cannabis permit for roughly $50 million. Two years earlier, comparable Virginia permits had carried implied valuations multiples higher. Distressed cannabis assets are trading at fractions of recent comparable valuations.

The buyer profile is also telling. The major distressed-asset purchasers in the current cycle are not cannabis-native companies. They are financial institutions — hedge funds, distressed-debt specialists, and private equity firms — that are buying cannabis licenses as financial assets, often with the intent to monetize through sale to operating companies in better times rather than building operating businesses themselves.

This is consistent with the broader transition the industry is undergoing. The first generation of cannabis ownership is exiting through forced sales. The second generation that emerges from this cycle will be more financialized, more concentrated, and less rooted in cannabis culture.

The Workers and Communities Caught in the Wake

The Cannabist's operations across roughly 18 states meant that the bankruptcy filing affected employees, vendors, landlords, and patients in markets nationwide.

Cultivation workers and retail staff in markets where the company is exiting operations face job losses, often with limited notice. Cannabis industry severance packages are typically minimal, and worker protections under WARN Act requirements may or may not apply depending on facility size and notice timing.

Vendors and small suppliers who provided goods and services to The Cannabist face the standard fate of unsecured creditors in cannabis bankruptcy: pennies on the dollar, if anything. Cleaning services, packaging suppliers, security providers, software vendors, marketing agencies — all join the line behind senior secured lenders and the IRS.

Patients in medical cannabis markets where The Cannabist operated face access disruptions. New York State medical cannabis patients who had been served by Cannabist locations now have to find alternative providers in a market that has chronically faced supply and access issues. Pennsylvania medical cannabis patients face similar transitions as the company winds down operations.

Local tax revenue in jurisdictions that had become dependent on The Cannabist's operations will be impacted, though the cannabis tax footprint in any single jurisdiction is rarely large enough to create acute fiscal stress.

What This Means for Other MSOs

The Cannabist filing is the test case that the rest of the MSO sector has been studying for months. Its outcomes will inform decisions that other companies make about their own restructuring options.

Several specific issues will get worked out in the proceedings. How the IRS treats accumulated 280E tax debt as a bankruptcy claim. How state cannabis regulators treat license transfers in bankruptcy contexts. Whether sale-leaseback REIT obligations can be restructured or rejected. Whether operating subsidiaries in different states can be reorganized separately. Whether assets can be sold across the U.S.-Canadian border efficiently.

Each of these questions has been argued in theoretical contexts. The Cannabist proceedings will produce actual rulings.

For lenders to other MSOs, the proceedings will reveal what recovery rates look like in cannabis bankruptcy. Early indications suggest those rates will be substantially lower than lenders modeled when they made the original loans, which will further tighten lending terms across the industry.

For the next-weakest MSO borrowers, the proceedings will determine whether bankruptcy is a viable controlled-restructuring tool or a wholesale value destruction event. If The Cannabist emerges from Chapter 11 as a smaller but viable operating company, others will follow. If the case devolves into a free-for-all asset liquidation, the next-weakest borrowers will fight harder to avoid filing — likely by accepting punitive refinancing terms that further impair their long-term prospects.

The Permanent Damage to the Sector Narrative

Beyond the specific financial outcomes, The Cannabist filing inflicts permanent damage on the cannabis industry's narrative to investors, regulators, and the public.

For more than a decade, cannabis advocates and operators have argued that legalization plus institutional investment plus regulatory clarity would produce a stable, profitable industry. The corollary argument was that cannabis MSOs would consolidate into mature, well-capitalized operating companies similar to alcohol or pharmaceutical brands, generating reliable returns for investors and reliable tax revenue for governments.

The Cannabist filing is the most prominent counterexample so far. A company that did everything the playbook said to do — multi-state expansion, vertical integration, public listing, professional management, brand investment — has filed for bankruptcy with $270 million owed and a fragmented operating footprint.

Investors paying attention will adjust their assumptions. Regulators considering policy changes will weigh the bankruptcy precedent. Future cannabis entrepreneurs will think harder about whether the MSO model is the right answer.

What Comes Next

The Cannabist proceedings will likely take 12–24 months to fully resolve. Asset sales will continue, possibly accelerating as the bankruptcy court oversees the process. Other MSO borrowers approaching maturity dates will watch the recovery numbers closely as they decide whether to negotiate refinancing or file their own protections.

For the broader industry, watch for:

A second major MSO bankruptcy filing within the next 6–12 months. Several candidates exist among the top-five borrowers identified in the $6 billion debt wall analysis.

Increased lender willingness to file involuntary bankruptcy petitions against weak borrowers, rather than waiting for borrowers to file voluntarily.

Federal regulatory action — either rescheduling movement or banking access — that could substantially change the financial structure of remaining cannabis operators. The political incentive for federal action increases as more high-profile bankruptcies occur in states whose representatives need to defend cannabis policy choices.

Distressed-asset funds becoming the dominant buyers of cannabis assets, with implications for the long-term character and ownership structure of the legal industry.

The Cannabist did not have to end this way. A different regulatory environment, a different financing market, a different competitive landscape might have produced a different outcome. But within the constraints that actually existed, the company made aggressive expansion bets that it could not service, accumulated tax obligations it could not pay, and ran out of refinancing options at exactly the moment the broader industry's debt wall arrived.

It is now an asset to be disposed of. So is the cautionary tale.

---

Cannabis.exposed tracks every major MSO restructuring as it develops. Subscribe for filings, court dates, and recovery analyses.

Internal links:

• The MSO Cartel: Inside the Price-Fixing Lawsuit →
• The $1.6 Billion the MSOs Owe the IRS →
• The $6 Billion Debt Wall →